NCT07289672

Brief Summary

The goal of this clinical trial is to increase the knowledge on what type of diet affects inflammation and how to better convay that information in patients with inflammatory bowel disease (IBD) and decrease selective eating in patients with IBD. The main questions it aims to answer are:

  • will the use of calprotectin as a control for changes in inflammation decrease selective food choices?
  • will the use of a digital information tool increase quality of life (QoL) och decrease selctive eating patterns?
  • will a diet based on nordic food choices decrease inflammation and increase QoL? Researchers will compare with IBD-patients in ordinary care. Participants will eat a test diet during six weeks or go through a digital information tool.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Feb 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Feb 2026Dec 2027

First Submitted

Initial submission to the registry

November 19, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 17, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

December 24, 2025

Status Verified

October 1, 2025

Enrollment Period

1.9 years

First QC Date

November 19, 2025

Last Update Submit

December 17, 2025

Conditions

Keywords

IBDulcerative colitisCrohn's diseasenutritional intervention

Outcome Measures

Primary Outcomes (1)

  • Concentration of calproteictin

    From enrollment until 6 weeks

Secondary Outcomes (1)

  • Four days registrered food intake

    At beginning and after 6 week

Study Arms (4)

Normal diet

NO INTERVENTION

Test diet calprotectin

EXPERIMENTAL
Other: Diet

Test diets Nordic

EXPERIMENTAL
Other: Diet

Digital information tool

EXPERIMENTAL
Other: education

Interventions

DietOTHER

Healthy nordic based food

Test diet calprotectinTest diets Nordic

Digital information tool/education on food in inflammatory bowel disease (IBD)

Digital information tool

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ulcerative colitis and Crohn's disease
  • Calprotectin 200-600

You may not qualify if:

  • Non-active disease
  • solely procitis
  • Severe disease
  • past extensive bowel surgery
  • treatment with antibiotics (last month or present)
  • pregnancy
  • unability to understand spoken or written Swedish
  • Multimorbidity which aggrevate participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mag- och tarmmottagningen, Skåne university hospital

Malmo, 20502, Sweden

Location

MeSH Terms

Conditions

Crohn DiseaseColitis, UlcerativeInflammatory Bowel Diseases

Interventions

DietEducational Status

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaSocioeconomic FactorsPopulation Characteristics

Central Study Contacts

Alexandra Vulcan, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Although the patients know that they will be given dietary advice they will not know what type of intervention the other group will be offered. Since dietary advice must be given by the investigators the study cannot be blinded to them.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2025

First Posted

December 17, 2025

Study Start

February 1, 2026

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

December 24, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations